Open-Labeled European Study To Support The Early Identification Of Patients With Chronic Neuropathic Low Back Pain In Primary Care And To Assess The Effectiveness And Tolerability Of Pregabalin In This Population.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2012
At a glance
- Drugs Pregabalin (Primary)
- Indications Back pain; Neuropathic pain
- Focus Therapeutic Use
- Acronyms PINPOINT
- Sponsors Pfizer
- 18 Apr 2012 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 14 Apr 2012 Additional trial locations (Finland and Greece) added as reported by European Clinical Trials Database.
- 06 Apr 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.